Global Blastomycosis Market Report By Product Type (Drugs, Ointment, Powder), By Application (Azoles, Polyenes, Echinocandins, Allyamines, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Drug Store) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Blastomycosis Market Report
Brand: Value Market Research
SKU: Healthcare
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11218108

December 2022

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Blastomycosis Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.

Blastomycosis is a fungus infection caused by the fungus Blastomyces. When Blastomyces spores are inhaled, they enter the body through the air, affecting the lungs and causing pneumonia. Cough, shortness of breath, exhaustion, back and chest pain, weight loss, and skin ulcers are some of the symptoms of blastomycosis. These disorders are more common in people who have a compromised immune system or diabetes. Itraconazole is administered orally in mild to moderate cases when the Blastomycosis infection spreads to the skin.

Market Dynamics

An increase in cases of chronic diseases, a rise in diagnosis procedures to detect chronic infection, increase in the bone marrow and organ transplantation procedures, rising haematological cancer cases, a surge in demand for amphotericin B therapy, rise in cases of immunological diseases, and an increase in the prevalence of human immunodeficiency virus (HIV) are factors that drive the growth of the blastomycosis market. In addition, increase in healthcare expenditure; availability of skilled professionals; collaborations & partnerships between key players to facilitate drug development; a rise in R&D activities to improve the quality of blastomycosis treatment drugs, rise in advancement of drug innovation such as fix dose combination, technological development such as computed tomography, tissue biopsy are some factors which boost the market growth for blastomycosis. However, the shortage of the drugs and high cost of treatment hinders the blastomycosis market growth. Contrarily, an increase in awareness regarding treatment and prevention of blastomycosis government initiatives for regulatory approvals are expected to offer lucrative opportunities for the expansion of the market.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of blastomycosis. The growth and trends of blastomycosis industry provide a holistic approach to this study.

Market Segmentation

This section of the blastomycosis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Drugs
Ointment
Powder

By Application

Azoles
Polyenes
Echinocandins
Allyamines
Others

By Distribution Channel

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Drug Store

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Blastomycosis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Blastomycosis Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the blastomycosis market include Abbott Laboratories, Pfizer Inc., Novartis, Sanofi S.A, Bayer, Merck and Company, Aglilent Technologies, Glaxosmithkline PLC, Sato Pharmaceuticals, Beckman Coulter inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot

3 . BLASTOMYCOSIS – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Product Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Distribution Channel
3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL BLASTOMYCOSIS MARKET ANALYSIS BY PRODUCT TYPE
6.1 Overview by Product Type
6.2 Historical and Forecast Data
6.3 Analysis by Product Type
6.4 Drugs Historic and Forecast Sales by Regions
6.5 Ointment Historic and Forecast Sales by Regions
6.6 Powder Historic and Forecast Sales by Regions

7 . GLOBAL BLASTOMYCOSIS MARKET ANALYSIS BY APPLICATION
7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Azoles Historic and Forecast Sales by Regions
7.5 Polyenes Historic and Forecast Sales by Regions
7.6 Echinocandins Historic and Forecast Sales by Regions
7.7 Allyamines Historic and Forecast Sales by Regions
7.8 Others Historic and Forecast Sales by Regions

8 . GLOBAL BLASTOMYCOSIS MARKET SALES ANALYSIS BY DISTRIBUTION CHANNEL
8.1 Overview by Distribution Channel
8.2 Historical and Forecast Data
8.3 Analysis by Distribution Channel
8.4 Hospital Pharmacy Historic and Forecast Sales by Regions
8.5 Online Pharmacy Historic and Forecast Sales by Regions
8.6 Retail Pharmacy Historic and Forecast Sales by Regions
8.7 Drug Store Historic and Forecast Sales by Regions

9 . GLOBAL BLASTOMYCOSIS MARKET SALES ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
9.3.1. Overview, Historic and Forecast Sales Analysis
9.3.2. North America By Segment Sales Analysis
9.3.3. North America By Country Sales Analysis
9.3.4. United State Sales Analysis
9.3.5. Canada Sales Analysis
9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
9.4.1. Overview, Historic and Forecast Sales Analysis
9.4.2. Europe by Segment Sales Analysis
9.4.3. Europe by Country Sales Analysis
9.4.4. United Kingdom Sales Analysis
9.4.5. France Sales Analysis
9.4.6. Germany Sales Analysis
9.4.7. Italy Sales Analysis
9.4.8. Russia Sales Analysis
9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
9.5.1. Overview, Historic and Forecast Sales Analysis
9.5.2. Asia Pacific by Segment Sales Analysis
9.5.3. Asia Pacific by Country Sales Analysis
9.5.4. China Sales Analysis
9.5.5. India Sales Analysis
9.5.6. Japan Sales Analysis
9.5.7. South Korea Sales Analysis
9.5.8. Australia Sales Analysis
9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
9.6.1. Overview, Historic and Forecast Sales Analysis
9.6.2. Latin America by Segment Sales Analysis
9.6.3. Latin America by Country Sales Analysis
9.6.4. Brazil Sales Analysis
9.6.5. Argentina Sales Analysis
9.6.6. Peru Sales Analysis
9.6.7. Chile Sales Analysis
9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
9.7.1. Overview, Historic and Forecast Sales Analysis
9.7.2. Middle East & Africa by Segment Sales Analysis
9.7.3. Middle East & Africa by Country Sales Analysis
9.7.4. Saudi Arabia Sales Analysis
9.7.5. UAE Sales Analysis
9.7.6. Israel Sales Analysis
9.7.7. South Africa Sales Analysis
9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE BLASTOMYCOSIS COMPANIES
10.1. Blastomycosis Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF BLASTOMYCOSIS INDUSTRY
11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Abbott Laboratories
11.3.1. Company Overview
11.3.2. Company Revenue
11.3.3. Products
11.3.4. Recent Developments
11.4. Pfizer Inc.
11.4.1. Company Overview
11.4.2. Company Revenue
11.4.3. Products
11.4.4. Recent Developments
11.5. Novartis
11.5.1. Company Overview
11.5.2. Company Revenue
11.5.3. Products
11.5.4. Recent Developments
11.6. Sanofi S.A
11.6.1. Company Overview
11.6.2. Company Revenue
11.6.3. Products
11.6.4. Recent Developments
11.7. Bayer
11.7.1. Company Overview
11.7.2. Company Revenue
11.7.3. Products
11.7.4. Recent Developments
11.8. Merck and Company
11.8.1. Company Overview
11.8.2. Company Revenue
11.8.3. Products
11.8.4. Recent Developments
11.9. Aglilent Technologies
11.9.1. Company Overview
11.9.2. Company Revenue
11.9.3. Products
11.9.4. Recent Developments
11.10. Glaxosmithkline PLC
11.10.1. Company Overview
11.10.2. Company Revenue
11.10.3. Products
11.10.4. Recent Developments
11.11. Sato Pharmaceuticals
11.11.1. Company Overview
11.11.2. Company Revenue
11.11.3. Products
11.11.4. Recent Developments
11.12. Beckman Coulter inc
11.12.1. Company Overview
11.12.2. Company Revenue
11.12.3. Products
11.12.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Blastomycosis Report
Market Research Process
Market Research Methodology
Global Blastomycosis Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Product Type
Market Attractiveness Analysis by Application
Market Attractiveness Analysis by Distribution Channel
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Product Type (USD MN)
Drugs Market Sales by Geography (USD MN)
Ointment Market Sales by Geography (USD MN)
Powder Market Sales by Geography (USD MN)
Global Market Analysis by Application (USD MN)
Azoles Market Sales by Geography (USD MN)
Polyenes Market Sales by Geography (USD MN)
Echinocandins Market Sales by Geography (USD MN)
Allyamines Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Analysis by Distribution Channel (USD MN)
Hospital Pharmacy Market Sales by Geography (USD MN)
Online Pharmacy Market Sales by Geography (USD MN)
Retail Pharmacy Market Sales by Geography (USD MN)
Drug Store Market Sales by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Top Company Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "

Market Dynamics

Market Segmentation

Regional Analysis